
Advancing clinical microbiology with sample-in/susceptibility-out diagnostic solutions
Funding reportedLast round: Series B
Follow GeneWEAVE and see its new rounds in your feed.Start following
Funding, as reported
Exit
Add your raise, your deck and your story, and put GeneWEAVE in front of investors. Or tell us what we have wrong.